Bafna Pharmaceuticals Ltd.

Contact Information

Legal Address
Bafna Towers,, New No. 68, Old No. 299,    , Thambu Chetty Street
Chennai; Tamil Nadu; Map
Postal Code: 600001
Tel: 25267517/ 42677555/
Fax: 25270992
Email: info@bafnapharma.com
Website: http://www.bafnapharma.com

Full name: Bafna Pharmaceuticals Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 2401582
IN-CIN: L24294TN1995PLC030698
ISIN: INE878I01014
Incorporation Date: 1995

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Capsules, Syrups, Injections, Tablets,
More

Company Description

Bafna Pharmaceuticals Limited engages in the manufacture and sale of pharmaceutical products. The company offers its products in various therapeutic areas, including anti-bacterials, anti-pyretics, antconvulsants, anxiolytics, pain management, anthelmintics, anti-fungal, appetite stimulants, antidiarrhoeals, antiemetics, hypnotics, antacids and anti-ulcerants, vitamin and dietary preparations, cough and cold preparations, anti-asthmatics, calcium preparations, anti-hypertensives, and anti-diabetics. Bafna…

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

Quote Chart

Quote Summary

Last Price 30.10
Volume 12,523
Turnover 379,447
Index
Market Bombay Stock Exchange
Ticker 532989
Market Cap Market Cap 681,956
52 Week High 50.45
52 Week Low 24.55
P/E 11.04
EPS 3.31
Dividend Yield
Bookvalue 1,311,753
Enterprise Value 1,055,351
Quote updated on July 27, 2016
Note: data in INR Thousands.

Export-Import

2014: Imports INR 23,746.31 Thousands
Import connections ('000)
Total(374.95)
2014: Exports INR 359.18 Thousands
Export connections ('000)
Total(5.67)

Key Executives

Company Secretary

Ownership Details

General Public
49.79%

Key Stats

Select Items to chart them. 2016 Y
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
EBITDA
Net Profit(Loss)
Total Assets N/A
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: Dion Global Solutions Limited, EMIS Company Database.

Financials

Competitors - India

INR | USD | EUR

Financial Documents/Annual Reports

Corporate Actions

Analysis/Research

EMIS DealWatch News

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Most recent financial data: 2016
Payment methods include:
USD 29.95
Most recent financial data: 2016
EMIS is able to provide you with immediate access to a full company report for Bafna Pharmaceuticals Ltd.. The table below indicates the information that your report will contain:
Payment methods include:
The full report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS Company Profiles are part of a larger information service where that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest